0.6004
price up icon2.06%   0.013
 
loading
Schlusskurs vom Vortag:
$0.5874
Offen:
$0.59
24-Stunden-Volumen:
156.62K
Relative Volume:
0.03
Marktkapitalisierung:
$20.01M
Einnahmen:
$570.00K
Nettoeinkommen (Verlust:
$-26.74M
KGV:
-0.9212
EPS:
-0.6517
Netto-Cashflow:
$-33.12M
1W Leistung:
+0.74%
1M Leistung:
+5.18%
6M Leistung:
+93.08%
1J Leistung:
-68.45%
1-Tages-Spanne:
Value
$0.5792
$0.6066
1-Wochen-Bereich:
Value
$0.5792
$0.609
52-Wochen-Spanne:
Value
$0.2805
$1.9933

Vyne Therapeutics Inc Stock (VYNE) Company Profile

Name
Firmenname
Vyne Therapeutics Inc
Name
Telefon
800-775-7936
Name
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Name
Mitarbeiter
10
Name
Twitter
Name
Nächster Verdiensttermin
2026-03-12
Name
Neueste SEC-Einreichungen
Name
VYNE's Discussions on Twitter

Compare VYNE vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VYNE
Vyne Therapeutics Inc
0.6004 19.57M 570.00K -26.74M -33.12M -0.6517
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
473.55 121.46B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
746.82 78.93B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
705.63 43.87B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.35 42.07B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
283.89 31.65B 5.36B 287.73M 924.18M 2.5229

Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-31 Herabstufung BTIG Research Buy → Neutral
2024-11-18 Eingeleitet BTIG Research Buy
2021-12-06 Fortgesetzt H.C. Wainwright Buy

Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten

pulisher
Mar 12, 2026

VYNE Therapeutics Inc. Files Form 8-K: Notice of Delisting from NASDAQ and Company Information (March 11, 2026) - Minichart

Mar 12, 2026
pulisher
Mar 11, 2026

VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance - TipRanks

Mar 11, 2026
pulisher
Mar 11, 2026

VYNE Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Mar 11, 2026
pulisher
Mar 07, 2026

Entry Recap: Can VYNE Therapeutics Inc sustain earnings growthOptions Play & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Aug Outlook: Can VYNE Therapeutics Inc expand its profit marginsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 05, 2026

Dividend Watch: What is the long term forecast for VYNE Therapeutics Inc stockJuly 2025 Closing Moves & Stepwise Swing Trade Plans - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 02, 2026

Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

Mar 02, 2026
pulisher
Mar 01, 2026

Technical Analysis: What analysts say about VYNE Therapeutics Inc stockJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

VYNE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026
pulisher
Feb 28, 2026

VYNE Should I Buy - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

VYNE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

VYNE: Losses narrowed in 2025 as the company pivots to a merger with Yarrow and exits key R&D programs - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Feb 27, 2026
pulisher
Feb 26, 2026

VYNE Therapeutics (VYNE) to Release Quarterly Earnings on Thursday - Defense World

Feb 26, 2026
pulisher
Feb 24, 2026

Aug Analyst Calls: Is Magnite Inc on track to beat earningsWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 21, 2026

How VYNE Therapeutics Inc. stock performs in rate cut cyclesWatch List & Consistent Income Trade Recommendations - mfd.ru

Feb 21, 2026
pulisher
Feb 21, 2026

Reviewing Avalo Therapeutics (NASDAQ:AVTX) and VYNE Therapeutics (NASDAQ:VYNE) - Defense World

Feb 21, 2026
pulisher
Feb 14, 2026

Why is VYNE Therapeutics Inc. stock going upTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

VYNE Therapeutics Inc. (NASDAQ:VYNE) Sees Large Decline in Short Interest - Defense World

Feb 14, 2026
pulisher
Feb 14, 2026

Published on: 2026-02-14 10:12:41 - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

What analysts say about VYNE Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trading Signals - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Can VYNE Therapeutics Inc. deliver consistent dividendsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Published on: 2026-02-12 18:59:51 - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Can VYNE Therapeutics Inc. benefit from deglobalizationPortfolio Update Report & Capital Efficient Trading Techniques - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Published on: 2026-02-09 22:57:29 - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 08, 2026

What analysts say about VYNE Therapeutics Inc stockEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 05, 2026

Portfolio Recap: Why is VYNE Therapeutics Inc stock going upBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 01, 2026

Trade Report: What is the long term forecast for VYNE Therapeutics Inc stockInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 30, 2026

Does MTCH stock have upside surprise potentialQuarterly Trade Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 30, 2026

VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience - TipRanks

Jan 30, 2026
pulisher
Jan 30, 2026

VYNE Therapeutics Signs Amendment to Merger Agreement With Yarrow Bioscience - TradingView

Jan 30, 2026
pulisher
Jan 29, 2026

Breakout Zone: Is VYNE Therapeutics Inc stock showing strong momentumTrade Performance Summary & Stock Market Timing Techniques - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

How cyclical is VYNE Therapeutics Inc.’s revenue stream2025 Winners & Losers & Long-Term Growth Portfolio Plans - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Decreases By 55.4% - Defense World

Jan 29, 2026
pulisher
Jan 26, 2026

Support Test: Can SunCar Technology Group Inc. scale operations efficientlyMarket Movers & Verified Swing Trading Watchlists - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 26, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Jan 26, 2026
pulisher
Jan 25, 2026

Block Trades: Is VersaBank a potential multi baggerJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 22, 2026

Is Sonoco Products Company exposed to currency risksMarket Growth Report & Verified Entry Point Signals - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Volume Summary: Is VYNE Therapeutics Inc stock showing strong momentumWeekly Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 21, 2026

Analysis Recap: What is the long term forecast for VYNE Therapeutics Inc stockQuarterly Growth Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 16, 2026

Weekly Earnings: Is SEALPRB stock a value trapJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Aug EndMonth: Why is VYNE Therapeutics Inc stock going upWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 09, 2026

Is VYNE Therapeutics Inc. stock positioned well for digital economyJuly 2025 Pullbacks & Safe Entry Trade Reports - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Will VYNE Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Trends & AI Enhanced Trading Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

US Stocks Recap: Will VYNE Therapeutics Inc stock remain a Wall Street favoriteJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Bộ Nội Vụ

Jan 08, 2026
pulisher
Jan 08, 2026

What insider trading reveals about VYNE Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Breakout Forecasts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 02, 2026

VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Down 18.2% in December - Defense World

Jan 02, 2026
pulisher
Dec 26, 2025

VYNE Therapeutics Inc. (VYNE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 26, 2025
pulisher
Dec 25, 2025

VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 25, 2025
pulisher
Dec 21, 2025

Vyne Therapeutics shares surge on merger deal with Yarrow Bioscience - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

Why VYNE Therapeutics Inc. stock remains resilient2025 EndofYear Setup & Entry Point Confirmation Signals - Улправда

Dec 21, 2025

Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):